Most Recent

Should the ACC Have a Live Meeting? 

The American College of Cardiology is planning to have some live participants at its annual scientific sessions meeting in May. The college said it is also partnering with a technology company to offer these participants a wearable monitoring device “as an added safety measure for monitoring possible COVID-19 symptoms.”
In my view both decisions are mistaken and send messages that are the exact opposite of what responsible medical and scientific organizations should be promulgating during the pandemic.

Chunkification of Clinical Trials: Why aren’t we adopting the Win Ratio more widely?

Most of us like our news (medical or otherwise) pre-digested into understandable chunks for consumption. This need for this is inevitable because we expect to…

Salt Intake, Life Expectancy and Mortality: A Not-So-Salty Story for the Holidays

Salt Intake, Life Expectancy and Mortality: A Not-So-Salty Story for the Holidays

Numerous publications attest to the observation that a high salt intake can trigger hypertensive cardiovascular disease de novo or accelerate pre-existing hypertension. For decades practicing physicians have warned their patients about excessive salt intake.

CVCT Forum 2020: An Interview with John Teerlink about Omecamtiv

What’s unique about omecamtiv? Darrel Francis speaks to GALACTIC-HF PI, John Teerlink about that dirty word in heart failure… “inotrope”. The new language is myotropes,…

The Defense of Science in the Age of Fake News

Fake news didn’t just become a problem because of Trump, or the pandemic. It’s been around for a long while. The problem can’t begin to be solved unless the medical and scientific community accepts that it has an absolute responsibility to aggressively debunk fake news and defend and support scientific principles.

Load More

Mission statement

CVCT CardioBrief will provide a platform for a diverse spectrum of opinions and perspectives on issues of interest to the cardiovascular clinical trials community. We aim to promote rigorous, unbiased, and patient-centred scientific discourse and debate within the cardiovascular community. CVCT CardioBrief does not seek to compete with medical journals or other traditional forums; instead we seek to create an accessible and responsive forum for discussion about important cardiovascular trials and other significant developments. It is our goal to provide a voice for perspectives that may not have always been able to gain exposure and consideration in traditional settings.

CVCT CardioBrief is an expansion of the CardioBrief website and is published by the CVCT Forum.

Would you like to write for CVCT CardioBrief? We are looking for brief original contributions of interest to the broad cardiovascular clinical trial community. We also invite readers to respond to posts and take part in the discussion on the site. Please send inquries or submissions to

Follow Us